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ABSTRACT 
 
 These studies were conducted to elucidate the regional analgesic effect that is 
observed clinically after treatment of orthopedic disorders with application of 
extracorporeal shock waves in horses. Regional analgesia after treatment with 
extracorporeal shock waves presents a concern because it may eliminate protective 
limiting mechanisms and may place equine athletes with predisposing lesions at risk of 
sustaining career- or life-ending injuries.  
 Direct percutaneous application of non-focused extracorporeal shock waves to 
palmar digital nerves in the pastern area of horses resulted in decreased sensory nerve 
conduction velocities compared with untreated control nerves at 3, 7, and 35 days after 
treatment. Transmission electron microscopy revealed distinct morphological changes 
consisting of extensive separation and disruption between the different layers of the 
myelin sheath in large- to medium-sized myelinated axons of treated palmar digital 
nerves. 
 Treatment of selected areas of the metacarpus in horses with non-focused 
extracorporeal shock waves failed to identify a regional analgesic effect when cutaneous 
sensation was assessed by comparing the nociceptive threshold (limb withdrawal reflex 
latency, LWRL) between treated and non-treated areas after stimulation with a focused 
light source. The LWRL responses in all horses were comparable in treated and control 
areas over time with a significant decrease noted at most sites and time points compared 
with baseline values. 
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CHAPTER 1 
GENERAL INTRODUCTION 
 Musculoskeletal disorders are the most prevalent cause of wastage in 
Thoroughbred racehorses and other performance breeds. Wastage is a term used to 
describe either the loss of horses from conception to adulthood, or the days lost by equine 
athletes due to inability to train or compete (Olivier et al. 1997). Musculoskeletal 
disorders reportedly have a major financial impact on the equine industry, both in terms 
of loss of athletic performance of the horse and expenses for diagnostics and treatments 
(Kobluk et al. 1990). 
 Extracorporeal shock wave therapy (ESWT) represents a new treatment modality 
used to treat selected orthopedic injuries in horses and appears to be gaining considerable 
interest and acceptance among veterinarians, trainers and horse owners. Extracorporeal 
shock waves (ESW) were first used in humans in the 1980’s to fragment renal and 
urinary bladder stones (Chaussy et al. 1980). Since 1985, concretions in other organs 
such as gallbladder, bile duct, pancreas and salivary glands have been treated with ESW 
(Iro et al. 1989; Iro et al. 1992; Sauerbruch et al. 1986; Sauerbruch et al. 1987). In the 
past ten years, ESW were also successfully used to treat a variety of orthopedic disorders 
in humans, such as fracture non-unions, pseudarthroses, osteochondrosis and various 
tendinopathies (Haupt 1997). Based on these encouraging results, ESW were adapted to 
treat orthopedic disorders in horses. 
 Extracorporeal shock waves are acoustic pressure gradient waves with a rise time 
of 5 to 10 nanoseconds (ns) to a peak pressure of up to 100 megapascals (MPa), followed 
by a rapid fall to negative pressure, before returning to baseline in a total pulse time of 
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approximately 300 ns (Sturtevant 1996). Two fundamentally different techniques are 
used to generate ESW, focused and non-focused generators (McClure and Merritt 2003). 
Focused ESW generators initiate pressure waves within a fluid medium. These waves are 
focused by reflection within the generator and directed toward a focal point in the body 
of the patient (Sturtevant 1996). Non-focused ESW or radial pressure waves are 
generated by mechanical concussion and transmitted into the patient’s body by use of a 
hand-held applicator. They are characterized by lower wave energies, a slower rise time 
than focused ESW, and a negative component that is approximately of the same order as 
the positive component (McClure and Merritt 2003). There is no focusing mechanism 
and the maximum energy generated by non-focused ESW is observed at the applicator-
patient skin interface and declines rapidly in proportion to the distance from the 
generator. Both types of ESW generators are currently used to treat orthopedic disorders 
in horses (McClure and Merritt 2003). 
 Although the exact mechanism by which ESW exert their effects in tissues is not 
fully understood, a transient local analgesic effect within shock wave-treated areas has 
been observed in humans and horses (Haupt 1997; McClure and Merritt 2003; McClure 
et al. 2003). Several painful soft tissue syndromes in humans, such as tennis elbow and 
golfer’s elbow, are currently treated using low energy ESW with considerable success 
(Haupt 1997). Local analgesia occurring after ESWT application is most likely 
independent of any other beneficial effect on tissue healing and could place equine 
athletes at risk of sustaining career-ending or life-threatening injuries, such as condylar 
fractures of the third metacarpus or metatarsus or breakdown of the suspensory apparatus 
of the fetlock, if exercised under the influence of local analgesia. These safety concerns 
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have been recognized by the equine industry and have recently resulted in development 
of regulations regarding the use of ESWT prior to training and competition by racing 
jurisdictions and the Federation Equine International (FEI). Due to the potentially 
catastrophic and fatal consequences of an analgesic effect that eliminates self-limiting 
protective mechanisms after ESWT application, side effects of this new treatment 
modality should be thoroughly investigated prior to widespread, uncontrolled application 
in performance horses. 
 The global hypothesis of this thesis was that ESW cause a transient local 
analgesic effect when applied to the distal limb in horses and that this effect is at least 
partially mediated by alterations in function and morphology of peripheral nerves within 
treated areas. To address these concerns, two studies were conducted. 
 The purpose of the first study was to identify functional changes in superficial 
peripheral nerves by measuring sensory nerve conduction velocities (SNCV) in palmar 
digital nerves directly treated with non-focused ESW compared with non-treated control 
nerves at different times after application. Additionally, it was intended to determine any 
relationship between changes in SNCV and morphologic changes in treated nerve 
segments by histology and transmission electron microscopy (TEM). It was hypothesized 
that SNCV in ESW-treated nerve segments would decrease, compared with non-treated 
control nerves, and that characteristic nerve lesions would be present after ESW 
application. 
 The purpose of the second study was to determine if a local cutaneous analgesic 
effect occurs after non-focused ESW application to the dorsal aspect of the third 
metacarpus in horses by using a standardized pain model and by comparing treated 
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versus non-treated control legs within the same animal. Additionally, it was intended to 
determine the interval of time of altered nociception in treated legs after ESW 
application. It was hypothesized that horses would exhibit an absent or delayed limb 
withdrawal reflex latency (LWRL) in ESW-treated legs in response to a painful stimulus 
with a focused light source. It was further hypothesized that the response to the pain 
stimulus would not be different in treated and non-treated limbs after attenuation of the 
local analgesic effect. 
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CHAPTER 2 
 
REVIEW OF LITERATURE 
 
2.1 Significance of Lameness in Performance Horses 
 Lameness represents an indication of a structural or functional disorder in the 
horse’s limbs or back that can be observed while the animal is standing or in motion 
(Stashak 2002a). Causes for lameness include trauma, congenital or acquired 
conformational anomalies, infections, metabolic disturbances, circulatory and nervous 
disorders, and various combinations of these (Stashak 2002a). Diagnosis and treatment of 
disorders causing lameness in horses are associated with considerable cost and have a 
major impact on the equine industry, both in terms of loss of athletic performance and 
amount of money spent for diagnostics and treatments (Ross et al. 1998).  
 A survey in a mixed horse population reported that common risk factors for 
lameness include athletic activity, housing in small operations, and the male or male-
castrated gender (Ross et al. 1998). For racehorses, a large amount of information is 
collected in data bases and multivariate techniques enable the investigation of individual 
risk factors for musculoskeletal injury and lameness, thereby allowing a more 
sophisticated approach to study the complex interaction between many variables. Risk 
factors identified for musculoskeletal injury in Thoroughbreds include age, sex, shoe 
type, track type and surface, track condition, season, intensity of racing and training, days 
since the last race, and type of racing activity (flat racing, hurdle or steeple chase) 
performed (Bailey et al. 1998; Estberg et al. 1996; Hernandez et al. 2001; Kane et al. 
1996; Mohammed et al. 1991). The properties of facilities for training and competition 
also appear to have a major influence on the occurrence of musculoskeletal injuries in 
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other performance horses. A study in racing Standardbreds showed that increasing the 
banking of the turns of the racetrack caused a significantly lower incidence of 
musculoskeletal injuries and lameness (Evans and Walsh 1997). 
 Wastage is a term used to describe both the phenomenon of lost performance in 
horses from conception to adulthood due to death or injuries (i.e. they never perform), or 
days lost due to inability to train or compete (Olivier et al. 1997). Multiple surveys in 
populations of Thoroughbred racehorses (Jeffcott et al. 1982; Kobluk et al. 1990; Lindner 
and Dingerkus 1993; Olivier et al. 1997; Rossdale et al. 1985; von Herzog and Lindner 
1992) and Standardbreds (Physick-Sheard 1986a; Physick-Sheard 1986b; Physick-Sheard 
and Russell 1986) consistently identified lameness as the most prevalent cause for 
wastage. With 72.1% and 67.6%, respectively, the percentage of training days lost 
attributable to disorders causing lameness was comparable between Thoroughbred 
racehorses in South Africa (Olivier et al. 1997) and England (Jeffcott et al. 1982). In a 
survey of Thoroughbred racehorses in Germany, musculoskeletal problems were 
responsible for 55.3% of the horses retiring from racing (von Herzog and Lindner 1992). 
A study in a different German racing Thoroughbred population attributed 57% of the 
wastage occurring due to lameness (Lindner and Dingerkus 1993). A survey within a 
Thoroughbred racehorse population in the United States reported an estimated 44% of 
horses having a musculoskeletal problem preventing them from training or racing 
anytime during the survey period, and an additional 32% of horses having a 
musculoskeletal problem requiring alterations in their training and racing schedules 
(Kobluk et al. 1990). During a single racing season in England, Jeffcott et al. (1982) 
observed the majority of causes for lameness in a population of 164 racehorses in the 
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forelimb (70%), with lesions in the foot (15.4%), dorsal metacarpus (15.4%), fetlock 
(15.0%), and carpus (12.6%) being the most prevalent sites of  lameness. In 21 cases 
(8.5%), the site of lameness could not be determined (Jeffcott et al. 1982). These findings 
are in agreement with another survey from England by Rossdale et al. (1985) who 
detected a comparable distribution of the sites of lameness in 198 racing Thoroughbreds 
over two seasons (Rossdale et al. 1985). However, the percentage of cases where the site 
of the lameness could not be localized (31.2%) was considerably greater than in Jeffcott’s 
survey. 
 In daily practice, the origin or the site of lameness in a horse is often suspected by 
a process of elimination of other (common) sites, but the exact origin may actually 
remain unknown (Rossdale et al. 1985). Many conditions that cause lameness respond 
favorably to restricted exercise and/or administration of non-steroidal anti-inflammatory 
drugs (NSAIDs), and precise localization of the cause of lameness is not attempted due to 
the time and costs associated with a thorough lameness examination including 
intrasynovial and peripheral nerve blocks, and diagnostic imaging (Rossdale et al. 1985).  
 Lameness is an important economical factor in performance horses, not only due 
to costs arising from diagnostics and treatments, but also due to the loss of generated 
income (money won). Lameness disorders therefore represent a challenge to the equine 
practitioner who wants to provide pain relief, reinstitute athletic use of the horse, and 
minimize economic loss, while at the same time operate within ethical and regulatory 
constraints of modern competition. This generates a growing interest in economical, 
alternative treatment modalities that appear to result in an improved and accelerated 
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healing process and shorter convalescence periods, such as extracorporeal shock wave 
therapy (ESWT). 
2.2 Extracorporeal Shock Waves 
2.2.1 Characteristics of Extracorporeal Shock Waves 
 Extracorporeal shock waves (ESW) are acoustic pressure gradient waves that are 
created by a generator and propagated into the patient’s body where they exert their 
effects on tissues. They are characterized by positive pressures of up to 100 megapascals 
(MPa), followed by a rapid fall to negative pressures of 5-10 MPa. One MPa corresponds 
to approximately 10 times the atmospheric pressure. Extracorporeal shock waves build up 
very rapidly with a rise time of 30-120 nsec, and their pulse duration is approximately 
300 to 500 nsec (Sturtevant 1996). Shock waves are differentiated from other acoustic 
waves (e.g. ultrasound waves) by their lower frequencies, their lower tissue absorption, 
and the absence of thermal effects within tissues. Therapeutic ESW travel nearly 
unchanged through fluids and soft tissues of the body and exert their effects at sites 
where there is a change in acoustic impedance along their path. Energy is released at 
these interfaces of different impedance values, and this creates compression and shear 
loads on the surface of the material with greater impedance. Rapid interaction between 
compression and shear forces results in a process referred to as cavitation. Microscopic 
gas bubbles are built up on the surface of the material with greater impedance and the 
collapse of these bubbles creates a small jet of liquid (fast flow) that causes high local 
stresses. Cavitation effects are believed to be responsible for the effects of ESW in tissues 
(Sturtevant 1996). 
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 Although the exact mechanism of how ESW exert their effects in tissues is poorly 
understood, four consecutive reaction phases are postulated to occur in the body (Haupt 
1997). In the physical phase, extracellular cavitations, ionization of molecules and an 
increase in cell membrane permeability occur as a direct effect of ESW. The subsequent 
physical-chemical phase consists of an interaction between diffusible radicals and 
biomolecules released from ESW-stimulated cells. This results in the chemical phase 
characterized by intracellular reactions and molecular changes in the cells. The biological 
phase is established if the changes occurring in the chemical phase persist (Haupt 1997). 
 Two fundamentally different types of shock waves (focused and non-focused 
shock waves or radial pressure waves) are used for extracorporeal shock wave therapy 
(ESWT) in humans and animals (McClure and Merritt 2003). Following their generation 
in a fluid medium, focused shock waves are concentrated (focused) and directed by 
reflection at target zones in the patient’s body (Sturtevant 1996). Focused ESW are 
created and focused from a wide arc so that at the site of actual wave generation, the 
amount of energy dispersed to the periphery is minimal (Sturtevant 1996). Via a focusing 
mechanism, each shock wave is directed toward a clearly defined point within the body 
of the patient; thus the wave energy concentrated at this point is extremely high. This 
point is referred to as the focal point and its location within the patient can be changed by 
adjusting the energy output (voltage) of the generator or by adjusting the focusing 
mechanism (Sturtevant 1996). In stationary focused ESW generators, diagnostic imaging 
techniques, such as fluoroscopy, radiography or ultrasound, are used to exactly localize 
the focal point (Schnewlin and Lischer 2001). This minimizes surrounding soft tissue and 
organ damage because the maximal (therapeutic) wave energy is reached only at the focal 
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point (Schnewlin and Lischer 2001; Sturtevant 1996). The energy that focused ESW 
exert at the focal point is expressed as energy flux density and is recorded in energy per 
surface area units (mJ/mm2). The more focused the emitted shock waves, the greater is 
the energy flux density achieved at the focal point (Sturtevant 1996). 
 Focused shock waves are generated by initiating a pressure wave within a fluid 
medium. Three different mechanisms are currently used to generate focused shock 
waves. Piezoelectric systems utilize a crystalline material that, when stimulated with high 
voltage electricity can expand or contract and initiate a pressure wave in surrounding 
fluid. Electromagnetic systems have coils that create opposing magnetic fields when an 
electric current is applied to them, causing a submerged membrane to move and generate 
a pressure wave in the surrounding fluid medium. Electrohydraulic systems create a 
plasma bubble via generation of a high voltage spark. Expansion of the plasma bubble 
compresses the surrounding fluid medium, thereby creating a pressure wave. Although all 
three mechanisms have different waveforms and energy characteristics, they all generate 
ESW that appear to be sufficiently intense to exert tissue effects at the focal point 
(Sturtevant 1996). Recently, portable electrohydraulic and piezoelectric systems have 
been introduced into the veterinary market to treat musculoskeletal disorders in horses. In 
these units, focused ESW are generated and reflected in handheld probes that are applied 
to the limb or body of the horse. 
 Non-focused extracorporeal shock waves or radial pressure waves are created by 
mechanical concussion and appear as expanding wave fronts that rapidly attenuate after 
their generation (Ammendolia et al. 2001; McClure and Merritt 2003). Compared to 
focused ESW, they are characterized by lower wave energies, a slower rise time, and a 
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negative component that is of the same magnitude as the preceding positive component 
(McClure and Merritt 2003). Non-focused ESW are not reflected or redirected toward a 
focal point in the patient’s body and their wave energy declines rapidly in proportion to 
the distance from the site of their generation. Non-focused ESW are transmitted up to 35 
mm into the patient’s body (Ammendolia et al. 2001). They are generated by 
transforming kinetic energy from an accelerated piston within a handheld applicator to 
mechanical force. The applicator is applied to the patient’s skin surface for treatment. 
Since non-focused ESW differ considerably form focused ESW, the term “shock wave” 
may be inappropriate to describe them (Schnewlin and Lischer 2001). However, 
beneficial effects in treatment of various orthopedic disorders in man (Gremion et al. 
2001; Lohrer et al. 2001a; Lohrer et al. 2001b) and horses (Boening et al. 2000; Palmer 
2002) with non-focused ESW have been reported. Due to their affordability and their 
small size, portable units for non-focused ESWT have gained substantial popularity in 
equine practice. 
2.2.2 Lithotripsy 
 Lithotripsy was the first reported medical application of ESW. The literal 
meaning of the term lithotripsy is “the act of breaking stones” (Adams and Senior 1999).  
Initially, mechanical devices were developed in human medicine to crush or fragment 
urinary concretions (uroliths) in the urinary bladder. These devices reduced uroliths to 
multiple fragments that could be flushed through a cystoscope sheath or pass the urethra 
without causing further obstruction (Adams and Senior 1999). The major drawback of 
these mechanical lithotripsy systems was their size, which precluded their use in more 
confined locations such as the urethra, ureter and renal pelvis. Their use in smaller 
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patients such as children, cats and small dogs was impractical, and these patients instead 
had to undergo open surgery procedures for the removal of urinary calculi (Senior 1984). 
 In the early 1970’s, Haeusler and Kiefer demonstrated that shock waves are 
capable of disintegrating human renal stones in vitro (Haeusler and Kiefer 1971). 
Subsequently, electrohydraulic shock-wave lithotripsy (EHL) was developed to fragment 
uroliths in people without the need for large crushing devices (Adams and Senior 1999). 
The EHL electrode generates a spark in the fluid surrounding the concretion. Generation 
and subsequent disappearance of this spark results in large pulse pressures (shock waves), 
which are absorbed by the concretion and lead to its disintegration (Watson 1970). 
Because the electrode wire used for EHL is quite small, this technique allows lithotripsy 
in less accessible anatomical locations, such as the urethra, ureter and renal pelvis 
(Adams and Senior 1999; Mitchell and Kerr 1977; Raney 1975). Electrohydraulic 
lithotripsy has also been used in veterinary medicine to disintegrate cystic calculi in dogs 
(Senior 1984), and cystic (Eustace and Hunt 1988; MacHarg et al. 1985) and ureteral 
(Rodger et al. 1995) calculi in horses. 
 The development of extracorporeal shock wave lithotripsy (ESWL) in the early 
1980’s was considered a major breakthrough in the treatment of uroliths, because it 
allows disintegration of stones in the upper urinary tract non-invasively from outside the 
body (Chaussy et al. 1980; Chaussy et al. 1982; Lingeman et al. 1987). In ESWL, shock 
waves are generated in the fluid medium of a wave generator and then transmitted 
percutaneously through the soft tissues of the patient to the urolith. Wave transmission 
into the body can be accomplished by submerging the patient in a water bath, or by using 
a fluid- or gel-filled cushion that is placed against the patient’s skin over the target area. 
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The latter is referred to as second or third generation or “dry” lithotripsy (Auge and 
Preminger 2002). Repeatedly administered shock waves cause disintegration of the 
urolith into small fragments that can be passed through the distal urinary tract. Currently, 
ESWL is considered to be the treatment of choice for 70 to 80% of people with uroliths 
(Chaussy and Fuchs 1989; Lingeman et al. 1987). An additional 25% of patients with 
more complex stones in the upper urinary tract can be treated with lithotripsy in 
combination with endourological procedures and do not have to undergo invasive open 
surgery (Chaussy and Fuchs 1989). 
 Extracorporeal shock wave lithotripsy has also been used to treat nephroliths and 
ureteroliths in dogs (Adams and Senior 1999; Block et al. 1996). In animals, ESWL must 
be performed under general anesthesia to allow for adequate positioning and analgesia. 
Approximately 30% of dogs treated with ESWL require two treatments to disintegrate 
uroliths into fragments that are sufficiently small to traverse the ureter (Adams and 
Senior 1999). These success rates are comparable with those of ESWL of nephroliths in 
people where first treatment success rates of 76% to 99% have been reported (Psihamis et 
al. 1992; Wilson and Preminger 1990). 
 Although ESWL of nephroliths was at first not believed to cause damage to the 
kidney (Chaussy and Schmidt 1984), studies in people, dogs, and minipigs showed that it 
causes intrarenal hemorrhage (Hill et al. 1990; Koga et al. 1996; Lingeman et al. 1989; 
Newman et al. 1987). The severity of damage caused by ESW depends on dose (voltage 
and number of shock waves) and frequency (number of shock waves per second) of the 
treatment (Lingeman et al. 1989; Newman et al. 1987). A study revealed that renal 
damage occurs mainly in the tubules and peritubular capillaries, and that the glomerular 
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filtration rate and renal blood flow return to pre-treatment levels by one week after 
ESWL (Hill et al. 1990). 
 After the successful introduction of ESWL for destruction of uroliths, concretions 
in other organs of human patients such as gallbladder, bile duct, pancreas and salivary 
glands have also been successfully treated with ESWL (Iro et al. 1989; Iro et al. 1992; 
Sauerbruch et al. 1986; Sauerbruch et al. 1987). 
2.2.3 Important Animal Models 
 Prior to the clinical application of ESW for the treatment of musculoskeletal 
disorders their effects on tissues were extensively investigated in animal models. Initial 
studies in piglets revealed a dose-dependent stimulation of wound healing in irradiated 
and non-irradiated split-thickness skin wounds (Haupt and Chvapil 1990). These findings 
led to the hypothesis that fracture healing might also be enhanced by shock waves.  
 Delius et al. (1995) observed periosteal detachment and extensive subperiosteal 
hemorrhage in specimens collected from rabbits immediately after a single application of 
focused shock waves to the stifle. Intense apposition of new lamellar bone and 
considerable cortical thickening of the bone were observed in samples that were obtained 
several weeks after treatment (Delius et al. 1995). Comparable observations were made in 
a dog model by Ikeda et al. (1999) after shock wave application to the femur (Ikeda et al. 
1999). Radiographic, histological and biochemical findings in a rat model suggested that 
fracture healing was stimulated by ESW (Haupt et al. 1990). These findings were 
corroborated in a canine model (Johannes et al. 1994), where all ESW-treated dogs 
demonstrated a radiographically evident bony union of an osteotomized radius at twelve 
weeks after a single treatment with focused ESW, compared with only one bony union 
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that was observed in the untreated control group (Johannes et al. 1994). In a sheep 
osteotomy model, treatment with focused ESW resulted in a smaller fracture gap and 
enhanced periosteal and endosteal bone apposition on radiographs (Ekkernkamp et al. 
1991). The radiographic findings in that study were confirmed by histological and 
fluorescence microscopic analysis where accelerated apposition of stable lamellar bone 
was observed (Ekkernkamp et al. 1991).  In a rabbit osteotomy model, ESW application 
resulted in such exuberant callus formation that the overall process of fracture healing 
and bone remodeling was actually delayed (McCormack et al. 1996). 
 Shock wave-induced bone formation and remodeling is believed to be caused by 
microfractures within the bone which act as local stimulators of bone remodeling 
(Kaulesar Sukul et al. 1993; Valchanou and Michailov 1991).  In a dog femoral 
osteotomy model, hemorrhage, detachment of the periosteum, and small fractures on the 
inner surface of the cortex were observed immediately after application of 500 or more 
focused ESW (Ikeda et al. 1999). Initial studies conducted in horses, however, failed to 
identify the presence of microfractures after treatment with focused ESW (McClure et al. 
2000). 
 In an attempt to investigate the effect of ESW on equine bone, McClure et al. 
(2000) applied 1,000 pulses of focused ESW dorsally to metacarpal and metatarsal bones 
of horses under general anesthesia. All animals were euthanatized immediately after 
treatment and treated and non-treated bones were evaluated macroscopically and 
microscopically. In agreement with studies in smaller species (Delius et al. 1995; Ikeda et 
al. 1999), ESW induced subperiosteal and endosteal hemorrhage at the application sites.  
However, no microfractures and no other lesions in skin, tendons, suspensory ligaments 
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and associated neurovascular structures of treated limbs were observed (McClure et al. 
2000). A recent histomorphometrical ex-vivo study in third metacarpal and metatarsal 
bone segments from horses revealed small but significant effects of ESW on the 
appearance of microcracks in cortical bone (Da Costa Gomez et al. 2004). Whereas 
application of focused ESW resulted in an increased density of bone microcracks 
compared with untreated bone segments, an increase in microcrack length was observed 
after non-focused ESW application (Da Costa Gomez et al. 2004). 
 Because of the proximity of many ESWT application sites to synovial joints, 
possible side effects of ESW on articular cartilage were investigated in a rabbit model by 
Vaeterlein et al. (2000). No significant radiographic, gross or histological pathological 
changes were observed in physeal and articular cartilage after ESW application to the 
femoral condyle in growing rabbits (Vaeterlein et al. 2000). 
2.2.4 Orthopedic Applications in Humans 
 2.2.4.1  Pseudarthrosis 
 In people, 0.5 to 10% of long bone fractures may exhibit delayed or insufficient 
healing and may ultimately result in pseudarthrosis (Bischof and Kinzl 2000). Success 
rates for treatment of pseudarthrosis with ESWT have been reported to vary between 
21% and 97% (Haist 1995; Haupt 1997; Ikeda et al. 1999; Schleeberger and Senge 1992). 
In one study, the patients were differentiated with regard to hypertrophic versus atrophic 
forms of pseudarthrosis based on radiographic criteria. While the majority of patients 
with hypertrophic pseudarthrosis revealed complete healing, healing after ESWT was 
rarely observed in patients with atrophic pseudarthrosis (Haist 1995). Complications 
following ESWT for pseudarthroses include transient local pain, petechial subcutaneous 
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bleeding and hematomas. These were observed in up to 4% of human patients (Haupt 
1997). 
 2.2.4.2  Hip Endoprosthesis 
 Implant instability has been identified as the most prevalent cause of failure in hip 
endoprosthesis (Ahnfeldt et al. 1990). This condition is usually addressed by replacement 
of the loose prosthesis. Extracorporeal shock waves have been investigated for their 
potential use to loosen the bone cement surrounding the implant in order to facilitate 
removal of the old prosthesis prior to replacement (Karpman et al. 1987; May et al. 1990; 
Weinstein et al. 1988). However, these attempts were unsuccessful and the failure was 
explained by the similar acoustic properties of bone and bone cement (Delius 1995; 
Weinstein et al. 1988).  
 2.2.4.3  Osteochondrosis 
 One investigator treated people with osteochondrosis dissecans of the stifle and 
talus with ESWT and observed re-attachment of fragments to the parent bone in several 
cases (Schleeberger 1995). Other ESW applications with promising results have also 
been performed in patients with Koehler’s Disease, Perthes’ Disease or Osgood-
Schlatter’s Disease (Haist and von Keitz-Steeger 1995; Schleeberger 1995). To date, 
however, it appears that the use of ESW for the treatment of osteochondrosis has to be 
considered experimental (Haupt 1997). 
 2.2.4.4  Calcific Tendonitis 
 Calcium deposits in the soft tissues of the shoulder represent a common and often 
incidental radiographic finding in people. Deposits develop most often in the 
supraspinatus tendon and can be detected in 2 to 20% of people without symptoms of 
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shoulder pain (Bosworth 1941). However, significantly more patients with shoulder pain 
(up to 50%) have calcium deposits (Bosworth 1941).  Spontaneous resolution of the 
calcium deposits and associated clinical signs has been observed in up to 100% of people 
with acute shoulder pain (Harmon 1958). However, chronic recurrent shoulder pain is 
often associated with persistent discomfort and calcium deposits on radiographs. 
Conventional treatment for calcific tendonitis includes physical therapy, NSAIDs, 
radiotherapy, steroid infiltration, needling (breaking up calcium deposits with 
hypodermic needles), and arthroscopic or open surgical procedures (Haupt 1997).  In one 
study, twenty patients with severe shoulder pain and calcium deposits of at least 1 cm 
diameter were treated with focused ESW. Twelve weeks later, seven patients showed 
complete radiographic disappearance of the deposits, whereas partial disintegration was 
observed in five patients. Six patients were completely pain-free, eight were substantially 
improved and only one patient experienced clinical deterioration (Loew et al. 1995). Two 
other case series of patients with calcific tendonitis reported complete resolution of 
shoulder pain or substantial clinical improvement in 73% and 83% of patients treated 
with ESWT, respectively (Haupt and Katzmeier 1995; Rompe et al. 1995). The specific 
mechanism of action of ESW on the calcium deposits is unknown.  One investigator 
postulated that resorption of the calcium deposits within the tendon occurs and that this 
process is preceded by mechanical breakdown and by reactive local neovascularization 
(Loew et al. 1995). The potential of ESW to induce neovascularization has recently been 
demonstrated in a canine model where new capillary-formation was observed at the 
tendon-bone interface of Achilles tendon specimens after application of low energy ESW 
(Wang et al. 2002). 
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 2.2.4.5  Soft Tissue Pain Syndromes 
 Painful tendinopathies in people, such as tennis elbow (epicondylitis humeri 
radialis), golfer’s elbow (epicondylitis humeri ulnaris), or shoulder pain (periarthritis 
humero-scapularis) have historically been treated with combinations of immobilization, 
physical therapy, radiotherapy and local steroid injections with variable success rates 
(Haupt 1997). Surgical treatments, such as the release of the common forearm extensor 
origin in severe cases of tennis elbow, are usually restricted to patients that are 
unresponsive to non-surgical treatment, but these procedures appear to yield good to 
excellent results (Haupt 1997; Verhaar 1994). 
 Dahmen et al. (1992) were the first to use ESWT to treat patients with soft tissue 
pain in proximity to bones. A variety of more than 30 different syndromes were treated in 
512 patients for whom surgery was originally intended.  Fifty-two percent of the cases 
experienced excellent results, 28% showed substantial improvement and only 3% 
ultimately required surgical procedures (Dahmen et al. 1992).  Haist and von Keitz-
Steeger (1995, 1996) reported success rates of 86% and 74% for treatment of tennis 
elbow and shoulder pain with focused ESW, respectively (Haist and von Keitz-Steeger 
1995; Haist and von Keitz-Steeger 1996). In another investigation, focused ESW were 
used to treat 150 people with tennis elbow that had undergone unsuccessful conservative 
treatment attempts for at least the previous three months (Rompe et al. 1995). A success 
rate of 84% in a population of patients that would otherwise have required surgical 
treatment was observed (Rompe et al. 1995). Lohrer et al. (2001) treated 55 patients with 
tennis elbow with up to three applications of non-focused ESW. Inclusion in this study 
required at least two unsuccessful conservative treatment attempts during the six months 
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previously and a clinical indication for surgical treatment. Fifty-six percent of the patients 
that were previously limited in their activities revealed resolution of all symptoms after 
12 months (Lohrer et al. 2001a). 
 The exact mechanism how ESW exert their reversible analgesic effect in soft 
tissue pain syndromes still needs to be elucidated. Clinically, a biphasic analgesic 
response is observed in people (Ogden and Ogden 2002). An immediate relief appears to 
be followed by a return of the pain at three to four days after treatment with ESW and 
then a second gradual improvement over the ensuing 3 to 4 weeks occurs (Ogden and 
Ogden 2002). 
 Haist and von Keitz-Steeger (1995) proposed three hypotheses for how ESW 
could induce local analgesia: 1) ESW induce cell membrane damage and non-functional 
nociceptors are subsequently unable to build up a membrane potential to transmit pain 
signals; 2) the nociceptors are over-stimulated by ESW and emit high frequency impulses 
that are modulated by a gate control mechanism; and 3) ESW-induced free radicals 
change the cellular environment and induce the release of unknown local pain-
suppressing substances (Haist and von Keitz-Steeger 1995). The gate control hypothesis 
is somewhat corroborated by the results of an ex-vivo study where electromyographic 
measurements from an isolated frog sciatic nerve in an organ bath revealed that 
approximately 95% of shock waves applied to the nerve were able to induce action 
potentials that were lower in amplitude but similar in shape to compound action 
potentials evoked by direct electrical stimulation (Schelling et al. 1994). With increasing 
dose and frequency of application, ESW are capable of inducing considerable 
morphological damage in peripheral nervous tissues. In one study, marked structural 
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abnormalities were observed in peripheral nerves of mice after application of high-energy 
ESW to the calf muscles (Smits et al. 1993). 
2.2.5. Orthopedic Applications in Veterinary Medicine 
 In the late 1990’s, ESW were introduced into veterinary medicine to treat 
musculoskeletal disorders in horses (McCarrol 1999). To date, however, no controlled 
studies for the use of this new treatment modality in horses have been published. Various 
case series reporting encouraging results for the treatment of orthopedic disorders in 
horses have been presented at scientific meetings (Boening et al. 2000; Crowe et al. 2002; 
McCarrol 1999; Palmer 2002; Scheuch et al. 2000). 
 Horses are usually treated with two to three treatments of medium to high-energy 
ESW administered at three-week intervals (Schnewlin and Lischer 2001). The hair over 
the target area is clipped and the shock waves are transmitted into the horse’s body 
through a fluid- or gel-filled cushion (focused ESW) or by placing the applicator with the 
piston against the horse’s skin (non-focused ESW). Use of a coupling gel is usually 
necessary to optimize shock wave transmission and to minimize energy loss. 
 Treatment with both non-focused and focused ESW can be associated with 
considerable irritation and may be resented by the animals. Sedatives and manual 
restraint (e.g. a nose twitch) are often necessary to administer the ESWT regimen in 
standing horses (Boening et al. 2000; Palmer 2002). Occasionally, peripheral nerve 
blocks are placed prior to ESWT application, or treatment is performed under general 
anesthesia (McCarrol and McClure 2000). 
 Non-focusing shock wave generators initially gained substantial popularity in 
equine practice due to their small size and their affordability. The comparison between 
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non-focused (radial) and focused ESW generators and their therapeutic effects appears to 
be somewhat difficult due to the different characteristics of the shock waves they 
generate. Recently, portable electrohydraulic and piezoelectric systems have been 
introduced into the veterinary market to treat musculoskeletal disorders in horses. 
 2.2.5.1  Suspensory Desmitis and Flexor Tendon Injuries 
 Lesions at the origin of the suspensory ligament account for approximately 5% of 
forelimb lameness in performance horses (Dyson 1992). Pain at the suspensory origin can 
be caused by suspensory ligament desmitis, torn Sharpey’s fibers at the insertion of the 
ligament, or even avulsion fractures of the origin (Bertone 2002). Flexor tendonitis, 
particularly tendonitis of the superficial digital flexor (SDF) tendon, is a common cause 
of lameness in racehorses and other performance horses (McIlwraith 2002). Lesions in 
these structures range from minor tearing of fibers to complete rupture of the tendon. 
Similar to suspensory desmitis, flexor tendonitis results in a high morbidity with a 
prolonged recovery period (McIlwraith 2002). 
 In one study, 30 horses with chronic suspensory ligament desmitis were treated 
with three applications of non-focused ESWT at two- to four-week intervals. Four weeks 
after the last treatment, 16 horses were free of lameness and 9 horses had improved at 
least one lameness grade (Boening et al. 2000). Donati et al. (2001) treated a total of 202 
performance horses with acute and chronic flexor tendon injuries or supensory ligament 
desmitis with focused ESWT under ultrasonographic control. Up to three treatments were 
administered to the horses standing under chemical restraint. After an average follow-up 
of 30 months, a complete resolution of clinical signs was observed in 87% of horses 
(Donati et al. 2001). 
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 2.2.5.2  Dorsal Metacarpal Disease 
 Periostitis and stress fractures of the dorsal surface of the third metacarpal bone 
constitute a spectrum of diseases that are commonly observed in young fast-gaited horses 
of two to three years of age (Bertone 2002). Although the greatest incidence is observed 
in Thoroughbred racehorses, it can also affect young Quarter Horses and occasionally 
racing Standardbreds. This disease complex is referred to as dorsal metacarpal disease 
(DMD) and is believed to occur due to a failure of the adaptive response of the third 
metacarpal bone to altered biomechanical stresses arising from high-speed training and 
racing (Bertone 2002). 
 Palmer (2002) treated 50 Thoroughbred racehorses with DMD with non-focused 
ESWT. All horses meeting clinical and radiographic inclusion criteria for the study had 
been treated unsuccessfully for at least two months previously with combinations of stall 
rest, restricted exercise, percutaneous periosteal scraping, osteostixis, and NSAIDs. After 
three treatments at three-week intervals, 40 horses (80%) resumed speed-work consisting 
of breezing and racing without lameness or other clinical signs associated with DMD 
(Palmer 2002). In another study, 10 horses with dorsal or palmar metacarpal cortical 
stress fractures were treated one to three times with focused ESW applied under 
ultrasonographic control.  Ninety days after the last treatment, eight horses (80%) had 
returned to racing or training and six (60%) were pain-free and/or revealed radiographic 
signs of fracture healing (Scheuch et al. 2000). 
 2.2.5.3  Degenerative Joint Disease 
 Degenerative joint disease (DJD) is the common end-stage of a large variety of 
joint disorders and is characterized by progressive deterioration of articular cartilage 
 24
accompanied by changes in the subchondral bone and the soft tissue components of  the 
joint (McIlwraith 2002). Pain and functional restriction associated with DJD account for 
a majority of clinically observed lameness disorders in horses. 
 McCarrol and McClure (2000) treated 75 horses with DJD of the distal intertarsal 
and tarsometatarsal joints (bone spavin) with one treatment of 2,000 pulses of 
electrohydraulic focused ESW. All horses were treated under general anesthesia and 
under fluoroscopic control. After ninety days, 59 horses (80%) had improved at least one 
lameness grade and 13 (18%) were completely sound. In all horses, no significant 
changes in radiographic findings (e.g. ankylosis of the distal tarsal joints) were observed 
compared with radiographs obtained prior to treatment. The investigators believed that 
clinical improvement in these horses resulted either from an ESW-induced analgesic 
effect or from altered shock absorption properties of the distal tarsal bones due to 
adaptive remodeling after treatment (McCarrol and McClure 2000). 
 2.2.5.4  Navicular Disease 
 Navicular disease represents one of the most common and controversial causes of 
intermittent forelimb lameness in horses between four and 15 years of age (Ackerman et 
al. 1977; Stashak 2002b). It has been estimated that navicular disease accounts for one-
third of all cases of chronic forelimb lameness in horses (Colles 1982).  
 Non-surgical treatment for navicular disease includes various types of corrective 
shoeing in combination with NSAIDs, medication with hemorheologic agents such as 
isoxsuprine hydrochloride, pentoxifylline and propentofylline, injection of corticosteroids 
and/or sodium hyaluronate in the distal interphalangeal joints or in the podotrochlear 
bursa, intramuscular injection of polysulfated glycosaminoglycans, and oral 
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supplementation of glucosamine hydrochloride and sodium chondroitin sulfate (Stashak 
2002b). Surgical treatment is usually reserved for cases that are unresponsive to non-
surgical treatment. Currently, palmar digital neurectomy represents the most commonly 
performed surgical treatment for navicular syndrome. This procedure desensitizes the 
caudal one-third to one-half of the palmar foot region and the sole extending dorsally to 
the toe (Stashak 2002b). 
 Garcia Lineiro and Echezarreta (2001) treated 15 horses with navicular disease 
with five treatments of 3,000 pulses of non-focused ESW at one week-intervals. All 
horses included in the study had clinical signs for over six months, presented with at least 
a grade 3/5 lameness, and had previously undergone unsuccessful medical and/or surgical 
treatment attempts. The ESW treatment was applied percutaneously over the palmar 
digital nerves and over the palmar surface of the navicular bone. In all animals, 
improvement of the lameness was observed after the third treatment and the lameness had 
completely resolved in all horses after the fifth treatment. All horses in the study 
remained sound for of at least 60 days (Garcia Lineiro and Echezzareta 2001). Another 
study reported on the treatment of 26 horses with one application of electrohydraulic 
focused ESW under general anesthesia. Complete resolution of lameness was observed in 
all horses after 6 months (Baer et al. 2001). In another investigation where lower doses of 
focused ESW were utilized, a substantially lower success rate was reported for the 
treatment of navicular disease (Scheuch et al. 2000). 
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2.3 Morphology and Function of Peripheral Nerves 
2.3.1 Anatomy and Physiology 
 The axons of peripheral nerves are surrounded by three different layers of 
connective tissue (Kimura 1989a). The endoneurium provides the supporting structure 
around individual axons within the nerve fascicles. The perineurium consists of 
collagenous tissue that binds each fascicle with elastic fibers and mesothelial cells. This 
layer also provides a diffusion barrier to regulate intrafascicular fluid (Ross and Reith 
1969). The epineurium is composed of collagen tissue, elastic fibers and fatty tissue and 
binds individual fascicles together (Kimura 1989a). 
 Peripheral nerves contain myelinated and unmyelinated fibers. Multiple inherent 
factors determine whether or not myelination of an axon will occur (Kimura 1989a). In 
myelinated fibers, the surface membrane of a Schwann cell (axolemma) spirals around 
the axon to form the myelin sheath. Each myelinated axon has its own Schwann cells, 
which regulate the myelin volume and thereby the thickness of the myelin sheath (Smith 
et al. 1982). The nodes of Ranvier, located at junctions between adjacent Schwann cells 
along the axon, represent gaps that are not insulated by Schwann cell processes. In 
myelinated nerve fibers, action potentials propagate from one node of Ranvier to another 
and the rate of propagation is approximately proportional to the fiber diameter. The 
spacing of the Schwann cells at the time of myelination determines the internodal 
distance. As the nerve grows in length during development, the internodal distance must 
increase because Schwann cells are unable to proliferate. Thus, the fibers myelinated 
early achieve larger diameters and wider spacing of the nodes of Ranvier (Vizoso and 
Young 1948). 
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 In contrast to myelinated axons, several unmyelinated fibers share Schwann cells 
that give rise to multiple separate processes, each surrounding one axon (Gamble and 
Eames 1964). In unmyelinated fibers, conduction velocity varies in proportion to the 
square root of fiber diameter (Kimura 1989a). 
 Axons of nerve cells have electrical properties common to all excitable cells in 
the body. The inside of the nerve fiber is negatively charged with a transmembrane 
steady-state potential that measures from -20 to -100 mV depending on the exact location 
(Kimura 1989a). The somatic membrane of the nerve cell body has less polarization (-70 
mV) than the axon (-90 mV). Application of a weak current to a nerve causes negative 
charges to accumulate outside the axon membrane, making the inside of the cell 
relatively more positive (cathodal depolarization). Under the positive pole (anode), the 
negative charges tend to leave the membrane surface, making the inside of the cell 
relatively more negative (anodal hyperpolarization). After about 10 to 30 mV of 
depolarization, the membrane reaches the critical level for initiation of an action potential 
with a consistent response, regardless of the kind of stimulus or its magnitude. An action 
potential initiated along the course of an axon propagates in both directions from its point 
of origin. Intracellular current flows from the active area to the adjacent negatively 
charged inactive area. An opposing current flows through the extracellular fluid from the 
inactive to the active region of the axon. This local current depolarizes inactive regions 
on both sides of the active area. Once it reaches the critical level, an action potential 
generates a new local current further distally or proximally along the axon (Kimura 
1989a).  
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 In myelinated fibers, action potentials can only occur at the nodes of Ranvier. 
This results in a local current jumping from one node to the next (saltatory conduction) 
instead of a continuous propagation as it is observed in unmyelinated fibers (Kimura 
1989a). 
 Various factors affect the time necessary for the generation of action potentials, 
which in turn determines the conduction velocity of an axon. Rapid propagation and fast 
conduction velocity result from faster rates of action potential generation, increased 
current flow along the axons, lower depolarization thresholds of the axonal membrane, 
and higher temperature which facilitates depolarization by increasing sodium 
conductance toward the intracellular fluid (Kimura 1989a). The longitudinal resistance of 
the axoplasm tends to inhibit the flow of local current. In myelinated axons, the 
capacitance and conductance of the internodal membrane have the same effect resulting 
in loss of current before it reaches the next node of Ranvier. This increases the time 
required to depolarize the adjacent nodal membrane, thereby decreasing conduction 
velocity. Both internodal capacitance and conductance decrease with myelin thickness. 
For a fixed axonal diameter, conduction velocity increases with myelin thickness only up 
to a certain point. An increase in myelin thickness has two opposing effects on 
conduction velocity; a larger axoplasmic resistance on one hand, and smaller membrane 
conductance and capacitance on the other (Waxman 1980). Damaged nerve fibers with 
demyelinated or partially remyelinated nerve fibers have an increased internodal 
capacitance and conductance because of their thin myelin sheath. More local current is 
lost to charge the capacitance and by leakage through the internodal membrane before 
reaching the next node of Ranvier (Kimura 1989a). Thus, demyelinated axons 
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characteristically have conduction failure, decreased conduction velocities, and temporal 
dispersion (Waxman 1980). 
 Conduction abnormalities in myelinated axons do not necessarily imply the 
presence of demyelination, but can also result from compression. The decreased fiber 
diameter in this case should actually facilitate conduction. Concomitant increase in 
resistance in the axoplasm, however, more than offsets this effect by delaying the flow of 
current to the next node of Ranvier (Kimura 1989a). 
 Peripheral nerves contain different groups of nerve fibers with different 
conduction velocities. Each class of nerve fibers is represented by a characteristic peak in 
the compound action potential (CAP) elicited by supramaximal electric stimulation 
(Kimura 1989b).  A-fibers represent afferent or efferent myelinated somatic axons. In 
sensory nerves, they are subdivided in four groups (I to IV), whereas in efferent muscle 
nerves they are subdivided into alpha and gamma motoneurons, according to their fiber 
diameter. Cutaneous somatic nerves contain myelinated alpha and delta A-fibers and are 
also subdivided according to their diameter.  The efferent unmyelinated C-fibers consist 
of the efferent postganglionic axons of autonomic nerves and the small afferent axons of 
the dorsal root and peripheral nerves. Several C-fibers share a single Schwann cell, unlike 
A- and B-fibers which are individually insulated. This and the absence of the myelin 
sheath allow histological identification of the C-fibers (Kimura 1989a).  
2.3.2 Classification of Nerve Injuries 
 Three degrees of peripheral nerve injuries have been described (Seddon 1943). 
Neuropraxia represents bruising or conduction loss without actual structural damage to 
the axon. Complete recovery usually takes place within days or weeks after removal of 
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the cause. The conduction velocity of the nerve, if initially slowed because of associated 
demyelination, returns to normal with repair of the myelin sheath. Mechanical factors 
have been identified as the major factor for the development of neuropraxia (Kimura 
1989b); however, short term changes in nerve conduction can also be induced by anoxia 
secondary to ischemia (Lewis et al. 1931). In axonotmesis, axonal damage results in the 
loss of continuity and Wallerian degeneration of the distal segment of the nerve fiber 
(Seddon 1943). Conduction block occurs immediately at the site of injury, followed by an 
irreversible loss of excitability, first at the neuromuscular junction, then at the distal 
nerve segment. The time course of Wallerian degeneration varies considerably among 
different species, but it does generally not occur until 4 or 5 days after acute interruption 
of nerve continuity (Gilliatt and Taylor 1959). Functional recovery depends on 
regeneration of nerve fibers and can take months or years due to their slow growth rate (1 
to 3 mm per day). Neurotmesis is referred to as an injury that separates the entire nerve 
and disrupts supporting connective tissue structures. Functional recovery after 
neurotmesis depends on whether the perineurium and the architecture of the nerve sheath 
were severed at the time of injury (Kimura 1989a). 
 2.3.3 Principles of Nerve Conduction Studies 
 Measurement of conduction characteristics represents a simple and reliable testing 
method of peripheral nerve function.  With adequate standardization, this method allows 
not only identification of a lesion in a nerve, but also precise localization of the site of 
maximal involvement. Electrical stimulation of a nerve is used to initiate an impulse that 
travels along motor, sensory, or mixed nerve fibers. Assessment of conduction 
characteristics depends on the analysis of evoked compound action potentials (CAP) that 
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are recorded either on the muscle if evaluating motor fibers or from the nerve itself if 
evaluating sensory nerve fibers (Kimura 1989b). Electrical stimulation is used in most 
clinical studies; however, tactile stimulation has also been shown to elicit recordable 
nerve action potentials (Buchthal 1965). In an ex-vivo study using frog sciatic nerves in 
organ baths, approximately 95% of shock waves that were applied to the nerve were able 
to induce action potentials that were lower in amplitude but similar in shape to the 
compound action potentials evoked by electrical stimulation in conduction studies 
(Schelling et al. 1994).  
 Surface electrodes or needle electrodes can be used for electrical stimulation of a 
nerve. Needle electrodes placed subcutaneously close to the nerve require much less 
current to elicit the same response in the nerve than surface electrodes applied to the skin 
(Kimura 1989b). Stimulating electrodes consist of a cathode (negative pole) and an anode 
(positive pole). Monopolar or bipolar electrical stimulation of the nerve can be 
performed, although the conduction velocities obtained by the two methods differ 
considerably. Most clinical studies use bipolar stimulation (Kimura 1989b). As the 
current flows between anode and cathode, negative charges that accumulate under the 
cathode depolarize the nerve. Conversely, at the same time, positive charges under the 
anode hyperpolarize the nerve. In bipolar stimulation, an anodal conduction block is 
avoided by placing the cathode closer to the recording site. An electromyographic 
stimulator is used to regulate the amount of current that is administered to stimulate a 
nerve. Constant-voltage stimulators are used to regulate the output in voltage, so that the 
actual current varies inversely with the impedance of electrode, skin, and subcutaneous 
tissues. In constant-current units, the voltage changes according to the impedance, so that 
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a specified amount of current reaches the nerve within certain limits of the skin’s 
resistance (Kimura 1989b). Electric stimuli can be classified on the basis of the 
magnitude of the evoked action potential. A threshold stimulus elicits a response in some, 
but not all axons contained in the nerve. A maximal stimulus activates all groups of axons 
and a further increase in stimulus intensity causes no additional increase in the amplitude 
of the evoked potential.  
 Surface and needle electrodes can be used to record evoked muscle and nerve 
potentials. Needle electrodes are preferred by some investigators to record sensory and 
mixed nerve action potentials because the amplitude of the recorded potential increases 
and the noise from the electrode tissue surface is decreased by a factor of two to three 
times over surface electrodes (Rosenfalck 1978). Ground electrodes are usually placed 
subcutaneously between stimulating and recording electrodes.  
 The potentials assessed during electromyographic procedures range in amplitude 
from microvolts to millivolts and an amplifying system using a storage oscilloscope or an 
electromyographic computer is usually required to record them (Kimura 1989b).  
 The most important parameters obtained by electromyographic diagnostic 
techniques include latency, amplitude of the evoked compound action potential, and 
conduction velocity. Latency is referred to as the interval between the onset of a stimulus 
to a nerve and the onset of the evoked response. Sensory nerve latency is only dependent 
on nerve conduction properties, whereas motor latency includes neuromuscular 
transmission (Kimura 1989b). The conduction velocity is the speed of propagation of an 
action potential along a nerve or muscle fiber (Kimura 1989b). For a nerve trunk, the 
maximum conduction velocity is calculated from the latency of the evoked potential at 
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maximal or supramaximal intensity of stimulation at two points. The distance between 
these two points (between stimulation and recording electrodes or between two different 
sets of recording electrodes along the nerve trunk) is the conduction distance and is 
divided by the difference between the corresponding latencies (conduction time) to obtain 
the conduction velocity (Kimura 1989b). The calculated velocity represents the 
conduction velocity of the fastest fibers and is expressed in meters per second (m/s). The 
compound nerve action potential is the summation of nearly synchronous nerve fiber 
action potentials recorded from a nerve trunk (Kimura 1989b). It is produced by direct or 
indirect stimulation of the nerve and its amplitude is measured from the most positive to 
the most negative peak. Under standardized circumstances, shape and amplitude of an 
evoked compound action potential can be indicative of axonal damage or dysfunction in a 
specific subset of nerve fibers (Kimura 1989b). 
 The validity of a calculated nerve conduction velocity depends on a variety of 
technical factors and influences from the subject. Accuracy in determining the latencies 
and the correct conduction distance are most imperative to obtain correct measurements. 
Other sources of error associated with the technique include incorrect triggering of the 
stimulus, poorly defined takeoff of the evoked response, inappropriate stimulus strength, 
and inaccurate calibration (Kimura 1989b; Simpson 1964). In people, nerve conduction is 
faster at warmer body temperatures (De Jesus et al. 1973). Alterations in nerve 
conduction velocities related to limb temperatures were also identified in horses (Wheeler 
1989). In people, both motor and sensory nerve fibers have furthermore been shown to 
conduct substantially more slowly in legs than in arms, which has been associated with a 
longer overall length of the nerves (Campbell et al. 1981; Kimura 1989b).  One study 
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comparing horses and ponies demonstrated a consistent inverse relationship between 
sensory nerve conduction velocities and animal height and nerve segment length (Blythe 
et al. 1988). 
 A clear association between age and conduction velocities has been demonstrated 
in people. Nerve conduction velocities nearly double their values between birth and 3 to 5 
years of age, thereby paralleling the process of advancing myelination (Thomas and 
Lambert 1960). As a function of age and growth in length, both motor and sensory nerve 
conduction velocities tend to slightly increase in the upper limb and decrease in the lower 
limb in later childhood and adolescence from age 3 to 19 years of age (Lang et al. 1985). 
Conduction velocities begin to decline after 30 to 40 years of age, but the values normally 
change by less than 10 m/s at 60 years of age (Taylor 1984). Studies in horses revealed an 
increase of sensory nerve conduction velocity over the first year of life followed by a 
subsequent decrease in older horses (Wheeler 1990). 
 The type of electromyographic abnormality is usually indicative of a specific kind 
of lesion in the affected nerve. Substantial slowing in conduction velocity implies 
demyelination of the sensory nerve fibers, whereas axonal damage with loss of continuity 
and Wallerian degeneration of the distal nerve segment (axonotmesis) results in reduced 
amplitude of the CAP with stimulation distal or proximal to the site of the lesion, or even 
total loss of response (Kimura 1989b). 
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CHAPTER 3 
 
FUNCTIONAL AND MORPHOLOGICAL CHANGES IN PALMAR DIGITAL 
NERVES FOLLOWING NON-FOCUSED EXTRACORPOREAL SHOCK WAVE 
APPLICATION IN HORSES 
 
3.1 Introduction 
 Extracorporeal shock wave therapy (ESWT) is a newly adapted treatment 
modality used to treat musculoskeletal disorders in horses (McClure and Merritt 2003). 
Various case series report successful treatment of soft tissue and bone disorders such as 
proximal suspensory desmitis (Boening et al. 2000; Crowe et al. 2002), dorsal metacarpal 
disease (Palmer 2002), navicular disease (Baer et al. 2001; Garcia Lineiro and 
Echezzareta 2001), and osteoarthritis of the tarsometatarsal and distal intertarsal joints 
(McCarrol and McClure 2000) with ESWT in horses. Although there is a paucity of 
controlled studies and the specific mechanism by which shock waves affect tissues still 
need to be elucidated, ESWT has become increasingly popular in equine practice. 
 Extracorporeal shock waves (ESW) are pressure gradient waves with a rise time 
of 5 to 10 ns and a peak pressure of up to 100 megapascals (MPa), followed by a rapid 
fall to negative pressure before returning to baseline in a total pulse time of 
approximately 300 ns (Sturtevant 1996). Wave energy is released at interfaces of tissues 
that have different acoustic impedances, resulting in compression and shear loads on the 
surface of the material with the greater impedance value. These loads result in a process 
called cavitation via development and collapse of microscopic gas bubbles. The 
collapsing gas bubbles invert and a small jet of liquid impinges on the surface of the 
material with greater impedance, thereby generating extremely high localized stresses 
(Sturtevant 1996). 
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 Two fundamentally different techniques are used to generate ESW. Focused 
shock wave generators were originally developed for the non-invasive destruction of 
urinary calculi in people (Chaussy et al. 1980) and were later adapted to treat a variety of 
musculoskeletal disorders (Haupt 1997; Rompe et al. 2001). Focused shock wave 
generators initiate a pressure wave within a fluid medium and the wave is focused by 
reflection within the generator toward a focal point in the patient (Sturtevant 1996). Non-
focused shock waves or radial pressure waves are generated by mechanical concussion. 
They are characterized by lower energies, a slower rise time than focused waves, and a 
negative component that is of the same order as the positive component. Their maximum 
wave energy is observed at the applicator-skin interface and declines rapidly in 
proportion to the distance from the generator (McClure and Merritt 2003). 
 Treatment with both focused and non-focused ESW has been reported to cause 
analgesia. This analgesic effect is most likely independent of any other potential 
beneficial effects on tissue healing and is observed rapidly after treatment. Clinical case 
studies in man (Haupt 1997; Rompe et al. 2001) and horses (Boening et al. 2000; 
McCarrol and McClure 2000) report substantial clinical improvement of various painful 
orthopedic conditions without concurrent radiographic changes.  
 Analgesia of an injured limb represents a concern in an equine athlete because it 
disables protective limiting mechanisms and may place horses with predisposing lesions 
at an increased risk of sustaining a catastrophic potentially career-ending or life-
threatening injury when exercised with altered peripheral pain perception. This has been 
recognized by the equine industry and has led to the development of safety regulations 
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concerning the use of ESWT prior to competition or training by racing jurisdictions and 
the Federation Equine International (McClure and Merritt 2003). 
 Extracorporeal shock wave therapy does not appear to be used to specifically treat 
peripheral nerves in man. In horses, nerves of the distal limb or structures in their 
immediate proximity are often treated directly or indirectly in order to provide relief from 
painful syndromes in the foot, such as navicular disease (Baer et al. 2001; Garcia Lineiro 
and Echezzareta 2001). There are no reports regarding the effects of ESWT on function 
and morphology of peripheral nerves in horses. 
  The objectives of this study were to demonstrate the post-treatment analgesic 
effect of ESWT by comparing sensory nerve conduction velocities (SNCV) in treated and 
untreated peripheral nerves in vivo and to document morphologic changes in ESWT-
treated nerve segments by histology and transmission electron microscopy (TEM) after 
palmar digital neurectomy. It was hypothesized that a single treatment with non-focused 
ESW applied directly over a peripheral nerve would result in decreased SNCV and 
noticeable morphologic changes. 
3.2 Materials and Methods 
3.2.1 Animals  
 The study was approved by the Institutional Animal Care and Use Committee of 
the Louisiana State University. A total of six horses were used in. Two Quarterhorses and 
four Thoroughbred horses (4 geldings, 2 mares) with mean bodyweight of 522 kg (range 
464 to 584 kg) and mean age of 14 years (range 5 to 17 years) were evaluated. Prior to 
inclusion in the study, animals were clinically evaluated and determined to be free of 
lameness. Horses were selected from a pool of animals used for research; individual 
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housing was provided at a nearby research facility. All horses were fed a routine 
complete pelleted diet and had free access to water.  
3.2.2 Extracorporeal Shock Wave Therapy 
 All six horses were treated with non-focused ESW on day 0 of the study. Prior to 
application of the ESW regimen, each horse was sedated with detomidine hydrochloridea 
(0.02 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight, 
IV). The hair on the palmar pastern of both front limbs was clipped and after application 
of a coupling gel provided by the manufacturer, 2,000 pulses with a non-focused shock 
wave generatorc were applied over the medial palmar digital nerve of the left forelimb. 
The regimen was administered at a frequency of 240 pulses/min., with a machine 
pressure of 0.25 MPa, using a 15-mm diameter applicator head. The same treatment was 
then administered to the left lateral palmar digital nerve. No treatment was administered 
to the right forelimb. The animals were returned to their stalls and daily hand-grazing was 
provided until subsequent experimental procedures. 
3.2.3 Sensory Nerve Conduction Velocity Measurements 
 Three groups of two horses each were evaluated at 3, 7, and 35 days following 
ESW application, respectively. The animals were sedated with xylazine hydrochlorided 
(0.5 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight, 
IV) and general anesthesia was induced with ketamine hydrochloridee (2 mg/kg of body 
weight, IV) and diazepamf (0.15 mg/kg of body weight, IV). Horses were placed in right 
lateral recumbency and anesthesia was maintained with isofluraneg and oxygen in a semi-
closed system. The pastern area and fetlock of both front limbs were aseptically prepared 
and draped, and a lateral abaxial 3-cm incision was made along the deep digital flexor 
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tendon in the mid-pastern area. The lateral palmar digital nerve was carefully isolated. A 
second 1-cm incision was made abaxially at the level of the lateral proximal sesamoid 
bone and the nerve was isolated at this site. A pair of sterile needle electrodes was placed 
directly into the nerve at the distal incision (stimulating electrodes) and at the proximal 
incision (recording electrodes). A ground electrode was placed dorsally into the skin 
between the stimulating and recording electrodes (Figure 3.1). The stimulating electrode 
was activated by a stimulator from an electromyography systemh (Figure 3.2). The 
recording and ground electrodes were connected to the preamplifier of the 
electromyographic recorder. The distance between stimulation and recording electrodes 
was measured with a sterile measuring tape and entered into the system computer. Square 
wave stimuli of 100 µs at 1 Hz were generated by the stimulator at various voltage 
settings until a visible compound action potential (CAP) was recorded by the recording 
electrodes and displayed on the system monitor (Figure 3.3). An average of 10 responses 
per nerve was recorded and measurements in each nerve were conducted in duplicate to 
demonstrate reproducibility. Sensory nerve conduction velocity (SNCV) in m/s was then 
calculated by the system computer and the average of both measurements for each nerve 
was recorded. Subsequently, the left medial and right medial palmar digital nerves were 
approached similarly through medial abaxial incisions and SNCV was measured as 
described above. 
3.2.4 Palmar Digital Neurectomy 
 Immediately after the SNCV measurements, a 4-cm long segment of the palmar 
digital nerve was resected and divided transversely with a sharp scalpel blade. 
Representative sections were placed in 10% neutral-buffered formalin for histological 
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evaluation and in primary fixative for transmission electron microscopy (1.25% 
glutaraldehyde and 2% formaldehyde in 0.1M cacodylate buffer). The incisions were 
closed with single interrupted skin sutures, using size 2-0 nylon suturei and bandaged. 
 
 Figure 3.1 - Photograph obtained during sensory nerve conduction velocity 
measurements in the left lateral palmar digital nerve in a horse under general anesthesia. 
The foot of the animal is draped off on the left side of the photo. Needle electrodes in 
contact with the nerve can be observed in the distal (S = stimulating electrodes) and 
proximal (R = recording electrodes) incisions. 
 
 Figure 3.2 - Position of the electrodes placed over the palmar digital nerves of 
horses for sensory nerve conduction velocity measurements. S = stimulating electrode, R 
= recording electrode, G = ground electrode, EMG = electromyography system, STIM = 
electromyographic stimulator. 
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 After recovery from anesthesia, the horses were returned to their stalls. The 
incision sites were kept bandaged until suture removal at two weeks after surgery. No 
complications from the surgery were observed. 
3.2.5 Histological Examination 
 Longitudinal and transverse sections of harvested nerve segments were fixed in 
10% neutral-buffered formalin, routinely embedded in paraffin, cut at a thickness of 4 µm 
on a rotary microtome,j and stained with hematoxylin and eosin (H&E) and luxol fast 
blue (LFB). Morphologic changes were described and each nerve was assigned a 
subjective histological score. Changes were described as mild (grade 1), moderate (grade 
2), and severe (grade 3) when the number of affected nerve fibers was less than 10%, 
between 10% and 40%, and more than 40%, respectively, in the examined sections. 
Sections with no microscopic findings were assigned grade 0. The pathologist was blind 
to the origin of the sample (treated vs. control nerves). 
3.2.6 Transmission Electron Microscopy 
 Representative 3-mm2 transverse sections of excised nerve segments were washed 
twice for 15 minutes in 0.1 mol/L sodium cacodylate containing 5% (W/V) sucrose. The 
buffer wash was followed by post-fixation in 1% OsO4 in distilled water for 1 hour. After 
several washes with distilled water, the nerve sections were stained overnight in 0.5% 
(W/V) uranyl acetate in distilled water. The samples were then dehydrated in graded 
ethanol solutions of increasing concentrations of 30%, 50%, 70%, 95% and 100%, 
infiltrated with Poly/Bed 812,k and polymerized. Polymerized blocks were sectioned into 
0.1-µm sections on an ultramicrotome.l The sections were stained with uranyl acetate and 
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lead citrate, and examined using a transmission electron microscope.m The investigator 
was blind to the origin of the sample (treated vs. control nerves). 
3.2.7 Data Analysis 
 SNCV was considered continuous and the proportional difference in SNCV for 
treated lateral and medial nerves, compared with control nerves within each horse, was 
analyzed using a mixed effect linear model that accounted for random variance of horse 
and limb, nested within time points. Ad-hoc comparisons were made within each nerve 
and across treated nerves at each time point, maintaining type I error at 0.05. Thus, where 
significance was determined, the p-value was set at ≤ 0.05, unless specified. A software 
programn was used for analysis. 
3.3 Results 
3.3.1 Sensory Nerve Conduction Velocities 
 Velocities for treated and control nerves for each horse were summarized (Table 
3.1). Careful surgical exploration and identification of the palmar digital nerves prior to 
needle placement for stimulating and recording electrodes resulted in reliable and 
reproducible SNCV measurements (Figure 3.3). Non-focused ESW caused a significant 
decrease in SNCV in all treated nerves, compared with control nerves, at days 3 and 7. A 
significant decrease in SNCV was also observed in treated medial but not lateral nerves at 
day 35. There was no difference in the magnitude of decrease between treated medial and 
lateral nerves on days 3 and 7. 
3.3.2 Histological Examination 
 Varying degrees of segmental axonal swelling were the only histological change 
observed. Swollen axonal segments had a pale, fine granular texture and were often  
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 Figure 3.3 - Compound action potential (CAP) recorded from a palmar digital 
nerve of a horse after electrical stimulation. O = onset, P = peak, T = through. Arrow = 
stimulus artifact. 
 
 Table 3.1 - Mean (individual values) of sensory nerve conduction velocities (m/s) 
and individual subjective histological severity scores in palmar digital nerves of horses 
treated with non-focused extracorporeal shock waves at 3,7, and 35 days after treatment. 
SNCV = sensory nerve conduction velocity, HSS = histological severity score, LL = left 
lateral palmar digital nerve, LM = left medial palmar digital nerve, RM = right medial 
palmar digital nerve (untreated control). There was no difference in magnitude of the 
decrease of SNCV for LL and LM nerves at days 3 and 7. Within each time point, “a” 
denotes a significant decrease in SNCV compared to controls (RM). 
 
Day post treatment Nerve SNCV HSS 
 LL 32.45a 
(32.7, 32.2) 
0, 2 
3 
 
LM 32.15a 
(34.9, 30.4) 
2, 1 
 RM 48.2 
(49.9, 46.5) 
2, 0 
 LL 37.0a 
(39.1, 34.9) 
2, 2 
7 LM 32.26a 
(34.9, 30.4) 
3, 3 
 RM 60.25 
(61.1, 59.4) 
2, 2 
 LL 51.95 
(61.7, 42.2) 
0, 0 
35 LM 37.9a 
(37.4, 38.4) 
2, 1 
 RM 43.35 
(44.7, 42.0) 
2, 1 
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 Figure 3.4 - Photomicrograph of a longitudinal section of the left medial palmar 
digital nerve of a horse at 7 days after treatment with non-focused ESW (grade 3 
histological severity score). Note the fine granular texture in swollen axonal segments 
(arrow) and the decreased cellularity of Schwann cells. Similar changes were observed in 
treated nerves and untreated control nerves. Bar = 50 µm, luxol fast blue stain. 
 
 
 Figure 3.5 - Photomicrograph of a longitudinal section of the untreated right 
medial palmar digital nerve (control nerve) of a horse at 3 days after treatment of the 
nerves on the opposite limb with non-focused extracorporeal shock wave therapy (grade 
0 histological severity score). No changes can be observed in myelinated (arrows) and 
unmyelinated nerve fibers and in surrounding Schwann cells. Bar = 50 µm, hematoxylin 
and eosin stain. 
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localized at only one end of longitudinal sections. No cellular infiltrates or hemorrhage 
was noted. Changes were observed in most treated and untreated nerve segments at 3, 7, 
and 35 days after ESW application (Table 3.1). Severely affected nerve segments had a 
decreased cellularity. The most severe changes were observed in left medial nerves at 7 
days after ESW application (Figure 3.4). Some of the control nerve samples and some of 
the treated nerve samples revealed no detectable changes (Figure 3.5). 
3.3.3 Transmission Electron Microscopy 
 Transverse sections of treated and untreated nerve segments were examined. 
Large- to medium-sized and small myelinated axons were observed. Non-myelinated 
axons were surrounded by neurolemmacytes and embedded in a loose collagenous 
endoneurium. In untreated nerves, concentric uniform myelin sheaths were evident in all 
myelinated axons and no traumatic or inflammatory changes were observed (Figure 3.6). 
Treated nerves at 3 (Figure 3.7), 7 (Figure 3.8) and 35 (Figure 3.9) days after ESWT 
revealed extensive separation and disruption between the different layers of the myelin 
sheath in large- to medium-sized myelinated axons, but no changes were observed in 
small myelinated and non-myelinated axons. As with untreated nerves, no traumatic or 
inflammatory changes were observed. 
3.4 Discussion 
 This study revealed that a single application non-focused ESW over a peripheral 
nerve results in a considerable decrease in conduction velocity and in separation and 
disruption of the layers of the myelin sheath in large- to medium-sized myelinated axons. 
A significant proportional difference in SNCV of ESW-treated versus untreated control  
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 Figure 3.6 - Photomicrograph obtained by transmission electron microscopy of a 
transverse section through an untreated control nerve. Large- to medium-sized (dark 
arrowheads) and small (light arrowheads) myelinated axons and numerous unmyelinated 
axons (dark arrows) can be observed. Bar = 10 µm. 
 
nerves was observed at 3 and 7 days following ESW treatment. Treated medial, but not 
lateral, nerves also had a significantly decreased SNCV at 35 days following ESW 
application.  
 It is believed that the absence of electrophysiologic changes in treated lateral 
nerves at 35 days after treatment is most likely attributable to a lack of precision during 
application of the ESW regimen and that the effects of  ESW application on conduction 
in peripheral nerves could most likely last beyond the follow-up period of the present  
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 Figure 3.7 - Photomicrograph obtained by transmission electron microscopy of a 
transverse section through the left medial palmar digital nerve of a horse at 3 days after 
treatment with non-focused extracorporeal shock wave therapy. There is separation 
between the myelin layers in large-to medium-sized myelinated axons (dark arrowheads). 
No changes can be observed in small myelinated axons (light arrowheads) and 
unmyelinated axons (dark arrows). Bar = 10 µm. 
 
study. Transmission electron microscopy consistently revealed separation and disruption 
of the layers of the myelin sheath of large- to medium-sized myelinated axons in treated 
nerves.  
 Histology revealed varying degrees of axonal swelling and cytoplasmic 
dissolution with a fine granular texture in both treated and control nerve samples at all 
time points. The histological changes have therefore to be considered artifacts that 
occurred most likely during the sensory SNCV measurements or during the subsequent 
palmar digital neurectomy. 
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 Figure 3.8 - Photomicrograph obtained by transmission electron microscopy of a 
transverse section through the left medial palmar digital nerve at 7 days after treatment 
with non-focused extracorporeal shock wave therapy. Severe disruption is evident in the 
myelin sheath of large- to medium-sized myelinated axons (dark arrowheads). There are 
no changes in small myelinated (light arrowheads) and unmyelinated axons (dark 
arrows). Bar = 10 µm. 
  
 Results of nerve conduction studies closely parallel the structural abnormalities of 
the nerve and depend on the type and degree of nerve damage. Partial demyelination and 
traumatic damage to the myelin sheath in myelinated axons has been shown to result in 
an impaired saltatory conduction due to an increase in internodal capacitance and 
conductance (Kimura 1989b). More local current is lost to charge the membrane 
capacitance and by leakage through the internodal membrane before reaching the next  
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 Figure 3.9 - Photomicrograph obtained by transmission electron microscopy of a 
transverse section through the left medial palmar digital nerve at 35 days after treatment 
with non-focused extracorporeal shock wave therapy. Large- to medium-sized myelinated 
axons (dark arrowheads) reveal similar changes as in Figure 3.8. There are no changes in 
small myelinated fibers (light arrowheads) and unmyelinated fibers (dark arrows). Bar = 
10 µm. 
 
node of Ranvier. Thus, axons with a damaged myelin sheath characteristically exhibit 
decreased conduction velocity and temporal dispersion (Kimura 1989b). Impaired nerve 
conduction without actual structural damage to the axonal cytoplasm is referred to as 
neuropraxia and represents the mildest form of peripheral nerve injury (Seddon 1943). 
 The electron microscopic findings could explain the decrease in SNCV values 
obtained in shock wave-treated nerves in the present study.  
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 The lack of electron microscopic changes in unmyelinated and small-sized 
myelinated axons in treated nerves was consistent and it may be speculated that these 
structures are either too small or provide an insufficient local change in impedance for 
ESW to exert their effects.  
 Lameness disorders represent a therapeutic challenge to the equine practitioner 
who wants to provide pain relief, reinstitute athletic use of the horse, and minimize 
economic loss while operating within ethical and regulatory constraints of modern 
competition. This has led to a growing interest in new, alternative treatment modalities 
that appear to result in an improved and accelerated healing process and a shorter 
convalescence period. Extracorporeal shock wave therapy represents such a modality and 
appears to be gaining interest and acceptance in the equine industry among veterinarians, 
trainers and owners for therapy of selected orthopedic injuries in horses. 
 Shock wave-induced stimulation of bone and soft tissue healing has been 
observed in man (Haupt 1997; Wild et al. 2000) and various animal species (Johannes et 
al. 1994; McClure and Merritt 2003; Wang et al. 2002), however, the exact effects of 
high pressure waves on tissues are not yet fully understood. Treatments with focused and 
non-focused ESW also seem to cause a transient analgesic effect within treated areas, 
apparently independent of any other beneficial effect on tissues (McClure and Merritt 
2003). The exact mechanism of this analgesic effect is unknown. Haist and von Keitz-
Steeger (1995) postulated three hypotheses for how shock waves induce analgesia in 
humans: 1) shock waves induce cell damage and the peripheral nociceptors can therefore 
not build up a membrane potential sufficient to transmit pain signals; 2) the nociceptors 
are overstimulated by shock waves and emit high frequency impulses to peripheral nerve 
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fibers, which are suppressed by a gate control mechanism; and 3) shock wave-induced 
pericellular free radicals induce the local release of unknown pain-suppressing substances 
(Haist and von Keitz-Steeger 1995). 
 In man, the analgesic response following ESWT appears to be bimodal. An 
immediate initial decrease in pain for 3 to 4 days is followed by a return of the pain and 
then a second gradual reduction in pain that occurs over the ensuing 3 to 4 weeks (Ogden 
and Ogden 2002). The initial response has been attributed to the direct effects of ESW on 
nociceptors and impaired substance P synthesis; whereas the second phase of pain relief 
was believed to result from a healing response associated with angiogenesis and tissue 
matrix remodeling (Ogden and Ogden 2002). A similar bimodal analgesic response can 
be observed clinically in horses undergoing ESWT to treat musculoskeletal disorders 
(McClure and Merritt 2003). 
 Musculoskeletal activity without full perception of peripheral pain could 
potentially place equine athletes with predisposing lesions at an increased risk of 
sustaining career-ending or life-threatening injuries such as condylar fracture of the third 
metacarpus or metatarsus, or breakdown injuries of the suspensory apparatus. This risk 
has been recognized by the equine industry and strict regulations concerning the use of 
ESWT before competitions have been issued by multiple racing jurisdictions and the 
Federation Equine International (McClure and Merritt 2003).  
 It has been recommended to avoid large nerves, blood vessels, and active growth 
plates when applying ESWT to horses (McClure and Merritt 2003). Because of the 
anatomical proximity of the target tissues to these structures, nerve trauma, however, 
cannot always be avoided, or it is occasionally even desired (Garcia Lineiro and 
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Echezzareta 2001). In horses, the palmar digital nerves may be treated directly or 
indirectly when ESWT is used to treat disorders in the foot, such as navicular disease 
(Baer et al. 2001; Garcia Lineiro and Echezzareta 2001).  Extracorporeal shock wave 
therapy does not appear to be used to specifically treat peripheral nerves in humans. 
 This study does not propose a conclusive explanation for the analgesic effect 
observed subsequent to ESWT in horses; however, it supports the premise that ESW 
cause damage to peripheral nerves resulting in slower conduction velocities and 
potentially impaired perception of peripheral pain. 
 Morphological and functional changes associated with neuropraxia are reversible 
over time (Kimura 1989b). Repeated application of ESWT, however, may cause more 
extensive damage to exposed peripheral nerves and may result in prolonged or permanent 
alterations in nerve conduction. Renal damage following extracorporeal shock wave 
lithotripsy (ESWL) of nephroliths in dogs has been shown to be cumulative depending on 
dose (voltage and number of shock waves) and frequency (number of shock waves per 
second) of the administered regimen (Lingeman et al. 1989; Newman et al. 1987). An 
experimental study also revealed dose-dependent morphological damage in the Achilles 
tendon of rabbits after application of ESW (Rompe et al. 1998). It may be speculated that 
administration of a greater total dose regimen of ESW may have resulted in prolonged 
duration of impaired nerve conduction and more extensive morphological damage in 
treated peripheral nerves.The duration of morphological nerve damage and impaired 
nerve conduction was not assessed beyond 35 days in the present study. The results of 
this study indicate that further research would be necessary to assess the effects of non-
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focused extracorporeal shock waves on peripheral nerves after a longer time period and 
after multiple treatments. 
 In conclusion, direct treatment of palmar digital nerves in horses with a single 
application of non-focused ESW resulted in a decrease of nerve conduction velocity and 
distinct alterations in the myelin sheath of large- and medium-sized myelinated axons. 
Although the small sample size of the present study limits the ability to draw a strong 
conclusion and despite the fact that the results do not provide a conclusive explanation 
for the analgesic effect observed in a clinical situation, cautious use of this treatment 
regimen is recommended in equine athletes before training or competition. 
3.5 Product Information 
aDormosedan, Pfizer, Inc., New York, NY. 
bTorbugesic, Fort Dodge Animal Health, Fort Dodge, IA. 
cSwiss ColorClast® Vet, EMS Electro Medical Systems, Dallas, TX. 
dXylaxine 100 Injection, The Butler Company, Columbus, OH. 
eKetaset, Fort Dodge Animal Health, Fort Dodge, IA. 
fDiazepam Injection, Abbott Laboratories, North Chicago, IL. 
gIsoFlo, Abbott Laboratories, North Chicago, IL. 
hCadwell Sierra EMG/EP, Cadwell Laboratories, Kennewick, WA. 
iEthicon, Johnson & Johnson, Somerville, NJ. 
jShandon AS325, Shandon Products, Pittsburgh, PA. 
kPoly/Bed 812, Polyscience, Inc., Warrington, PA. 
lMT-XL, RMC Products by Boeckeler Instruments, Inc., Tucson, AZ. 
mZeiss (LEO) EM-10C, Oberkochen, Germany. 
nPROC MIXED, SAS V8.0, SAS Institute, Inc., Cary, NC. 
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CHAPTER 4 
 
EVALUATION OF THE LOCAL ANALGESIC EFFECT AFTER NON-
FOCUSED EXTRACORPOREAL SHOCK WAVE APPLICATION TO THE 
THIRD METACARPAL BONE IN HORSES 
 
4.1 Introduction 
Periostitis and stress fractures of the dorsal cortex of the third metacarpal bone 
represent conditions that are often observed in young fast-gaited performance horses at 
two to three years of age (Bertone 2002). This disease complex is referred to as dorsal 
metacarpal disease (DMD) and is believed to occur because of a failure of the adaptive 
response to altered biomechanical stresses that arise from high-speed work (Bertone 
2002). Racing Thoroughbreds have the greatest prevalence of DMD, but young Quarter 
Horses and occasionally racing Standardbreds can also be affected (Bertone 2002). 
Conventional treatment of DMD includes combinations of stall rest, altered 
training regimens, and systemically administered non-steroidal anti-inflammatory drugs 
(NSAIDs), percutaneous periosteal scraping, and osteostixis. Alternative treatment 
modalities, such as cryotherapy (Montgomery et al. 1981), and more recently, 
extracorporeal shock wave therapy (Palmer 2002; Scheuch et al. 2000), have also been 
reported for the treatment of DMD. In a clinical report on 50 Thoroughbred racehorses 
with DMD that were unresponsive to conventional treatment and were treated with 
pneumatically generated non-focused extracorporeal shock wave therapy (ESWT), 40 
horses (80%) resumed speed work without recurrence of lameness or other clinical signs 
associated with DMD after three treatments at three-week intervals (Palmer 2002). In 
another case series, 10 horses with dorsal or palmar metacarpal cortical stress fractures 
were treated with one to three applications of focused ESWT administered under 
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ultrasonographic control (Scheuch et al. 2000). Ninety days after treatment, eight of ten 
horses had returned to racing or training and six were pain-free and/or revealed 
radiographic signs of fracture healing (Scheuch et al. 2000). Despite the lack of reliable 
controls, these reports suggest that ESWT may be useful for treatment of DMD. 
Extracorporeal shock waves are acoustic pressure gradient waves that are used to 
treat a variety of musculoskeletal disorders in people and animals. Although first 
introduced for non-invasive treatment of urolithiasis in man (Chaussy et al. 1980), ESW 
were subsequently investigated for their effect on wound healing (Haupt and Chvapil 
1990) and their osteogenic potential (Ikeda et al. 1999; Johannes et al. 1994). Humans are 
currently treated with ESWT for a variety of conditions including fracture non-unions 
(Haupt 1997; Valchanou and Michailov 1991) and painful soft tissue syndromes such as 
plantar calcaneal spurs (Rompe et al. 2003) and tennis elbow (Rompe et al. 2001). 
Several clinical investigations in horses reported promising results in the treatment of a 
variety of disorders such as bone spavin (McCarrol and McClure 2000), stress fractures 
(Scheuch et al. 2000), high suspensory desmitis (Boening et al. 2000; Crowe et al. 2002) 
and navicular disease (Baer et al. 2001; Garcia Lineiro and Echezzareta 2001). Horses are 
often treated using non-focused ESW or radial pressure waves that are characterized by 
their distinct physical characteristics including lower wave energies, a slower rise time, 
and their inferior penetration into the patient’s body compared to focused ESW (McClure 
and Merritt 2003). However, beneficial effects in treatment of musculoskeletal disorders 
with non-focused ESW have been reported in people (Gremion et al. 2001; Lohrer et al. 
2001a; Lohrer et al. 2001b) and horses (Boening et al. 2000; Crowe et al. 2002; Palmer 
2002). 
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 Although the precise mechanism by which ESW exert their effect on tissues are 
currently not known, transient local analgesia of the treated areas has been observed in 
people (Ogden and Ogden 2002) and horses (McClure and Merritt 2003). This analgesic 
effect is likely to be independent of any other beneficial effect on healing of injured 
structures and could place performance horses with predisposing bone and soft tissue 
lesions at risk of sustaining a life- or career-threatening injury when exercised too 
strenuously after application of shock wave therapy. Recognition of these safety concerns 
has resulted in the development of regulations concerning the use of ESWT prior to 
competition and training by racing jurisdictions and the Federation Equine International 
(McClure and Merritt 2003). 
 The purpose of this study was to evaluate the local cutaneous analgesic effect of 
ESW in the distal limb of horses. It was hypothesized that a single treatment with non-
focused ESW applied dorsally to the third metacarpal bone would induce a transient local 
analgesic effect and that altered peripheral pain perception could be assessed by 
evaluating the response to a standardized thermal cutaneous pain stimulus. The specific 
objective was to compare the latency of onset, magnitude and duration of analgesia in 
metacarpal areas treated with non-focused ESW to non-treated areas. 
4.2 Materials and Methods 
4.2.1 Animals 
 The study was approved by the Institutional Animal Care and Use Committee of 
the Louisiana State University. Twelve adult horses from the institutional research herd 
were used in the study: Five Quarter Horses (three geldings, two mares), six 
Thoroughbreds (four geldings, two mares) and one Arabian with a mean age of 14 years 
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(range five to 19 years). Prior to inclusion in the study, all animals were clinically 
evaluated and determined to be free of lameness and apparent abnormalities in their 
metacarpal bones. Individual housing was provided at a nearby research facility and all 
horses were fed a routine complete pelleted diet and had free access to water.  
4.2.2 Extracorporeal Shock Wave Therapy 
 Prior to ESW application, each horse was sedated with detomidine hydrochloridea 
(0.02 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight, 
IV) and the hair on the medial, lateral and dorsal aspect of both metacarpi was clipped. 
One forelimb of each animal was randomly assigned to be treated. The skin of five 
circular areas (1.5 cm diameter) on the treated metacarpus (lateral-mid-diaphysis = area 
1; dorsal-mid-diaphysis = area 2; medial-mid-diaphysis = area 3; dorsal-proximal 
diaphysis = area 4; dorsal-distal diaphysis = area 5) and on one area on the control limb 
(dorsal metacarpal mid-diaphysis = area 6) of each animal were darkened with a black 
ink felt pen to improve light absorption for assessment of the limb withdrawal reflex 
latency (LWRL). After application of a coupling gel provided by the manufacturer, 2,000 
pulses with a non-focused ESW generatorc were applied over each of the three mid-
diaphyseal circular areas of the treatment limb (areas 1, 2, 3). The regimen was 
administered at a frequency of 240 pulses/min., with a machine pressure of 0.25 MPa, 
using a 15-mm diameter applicator head. The proximal and distal diaphyseal areas on the 
treated limb (areas 4 and 5) and the mid-diaphyseal area on the opposite limb (area 6) 
served as controls (Figure 4.1).  
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Figure 4.1 - Areas for evaluation of the limb withdrawal reflex latency (LWRL) 
on the third metacarpal bones of horses treated with non-focused extracorporeal shock 
waves. A = shock wave-treated limb. B = untreated control limb. 1, 2, 3 = treated areas.  
4, 5, 6 = untreated control areas. 
 
4.2.3 Assessment of the Limb Withdrawal Reflex Latency 
 The degree of cutaneous analgesia caused by non-focused ESW was quantified by 
assessment of alterations in a nociceptive threshold, using a focused light beam as a 
stimulus. Briefly, horses were led into the testing area and a focused beam of light of a 
standardized intensityd was emitted from a distance of 20 cm onto the target areas on the 
third metacarpal bones. The time from stimulus when the light beam was emitted until 
withdrawal of the limb was observed, and this response was designated as the limb 
withdrawal reflex latency (LWRL). Baseline measurements were obtained in both treated 
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and control areas prior to application of the ESW regimen. Following treatment of the 
designated areas, LWRL was assessed in random order in all areas of both limbs every 
two hours for 12 hours, followed by measurements every eight hours for 48 hours after 
treatment. Each LWRL measurement was repeated three times in each area. 
4.2.4 Data Analysis  
 Time to withdrawal from the light source was considered continuous, and 
determined to follow a normal distribution, using the Shapiro-Wilk test with rejection of 
the null hypothesis of normality at p≤ 0.05. Results were summarized as mean ± SEM. 
Using each horse as its own control (blocking by horse), the effects of treatment and time 
were evaluated, using a mixed effect linear model accounting for the random variance of 
horses and repeated measurements on each horse. Where there were significant main and 
interaction effects, selected multiple comparisons were made to determine the between 
treatment effects at various time points and the effect of time within treatments. A 
software programe,f was used for analysis. 
4.3 Results 
 Application of non-focused ESW was well tolerated by all horses. Eight of the 12 
horses developed mild to moderate swelling and skin abrasions over the treated areas. 
These changes were observed immediately after the end of ESW application. 
 The LWRL responses were similar in all treated and control areas over time with 
a significant decrease noted at most areas and time points compared with baseline 
measurements. 
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Table 4.1 - Mean ± (SEM) limb withdrawal reflex latency values of horses after application of non-focused shock waves to the 
metacarpus. Areas 1, 2, 3 = treated areas on mid-diaphysis of the treated limb; areas 4, 5 = untreated control areas on the treated limb; 
area 6 = mid-diaphyseal area on the opposite limb (untreated control). Within each treatment area (row), “a” denotes means that are 
significantly (p ≤ 0.05) different from the baseline measurements. Within each time point (column), “b” indicates means that are 
significantly (p ≤ 0.05) different from area 6 (untreated control). 
 
 Hours after treatment 
Area Baseline 2 4 6 8 10 12 20 28 48 
1 13.41 (1.71) 10.76 (0.89)a 8.96 (0.54)a 7.76 (0.55) a 7.32 (0.35) a, b 6.93 (0.35) a b 6.32 (0.45) a, b 9.36 (1.18) 6.68 (0.41) a 8.11 (1.00) a, b 
2 15.18 (1.65) 11.73 (1.36) 10.46 (0.82) a 8.27 (0.84) a 7.64 (0.59) a, b 7.36 (0.62) a 6.96 (0.44) a, b 9.43 (1.14) a 7.06 (0.37) a 8.06 (1.15) a, b 
3 17.66 (2.54) 12.11 (0.10)a 9.66 (0.92) a 8.52 (0.74) a 8.05 (0.44) a, b 7.32 (0.46) a 7.82 (0.59) a, b 11.80 (2.70) a 7.08 (0.60) a 8.95 (1.02) a 
4 13.47 (1.28) 10.89 (0.87) 9.17 (0.75) a 8.30 (0.88) a 7.28 (0.59) a, b 7.18 (0.55) a b 8.13 (0.46) a 9.13 (1.20) a 6.89 (0.48) a 9.44 (1.16) 
5 14.79 (1.59) 11.70 (0.42) 10.04 (0.80) a 8.26 (1.13) a 8.92 (0.80) a 8.05 (0.67) a 7.48 (0.62) a b 8.53 (1.14) a b 9.44 (2.01) a 9.99 (1.27) a 
6 17.26 (2.45) 12.43 (0.72)a 10.84 (1.20) a 9.36 (0.75) a 11.06 (1.38) a 9.53 (0.83) a 10.06 (0.82) a 14.55 (1.72) 9.44 (0.64) a 13.21 (1.79) 
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Between point comparisons at different times after treatment revealed no significant 
difference between areas during baseline LWRL measurements, and at 2, 4, 6 and 28 
hours after ESW application (Table 4.1). There was a significant decrease in LWRL at 
most areas on the treated limb, compared with the control area on the opposite limb (area 
6), at 8, 10, 12, 20 and 48 hours after treatment. 
4.4 Discussion 
 Non-focused ESW applied to the third metacarpal bone of horses had no 
noticeable effect on LWRL in the present study. A significant decrease in LWRL was 
observed over time, but there was no difference between treated and control areas on 
ESW-treated metacarpi and control areas on the opposite limbs. Because swelling and 
skin abrasions were observed in several horses, a local inflammatory response secondary 
to treatment-induced trauma could potentially have overwhelmed any local cutaneous 
analgesic effect. However, considering the similarity of the findings in treated and 
untreated areas over time, it appears more likely that no local analgesia resulted from 
ESW application. Tissue trauma and inflammation after ESW application may have 
induced hypersensitivity in all testing sites of the treated limbs. This could be somewhat 
corroborated by the significant decrease of LWRL in some areas of the treated limb, 
compared with the control area on the opposite limb (area 6), at 8, 10, 12, 20 and 48 
hours after treatment. Another explanation for the progressive decrease of LWRL in all 
tested areas over time could be that the horses became conditioned to testing during the 
study and that a painful thermal stimulus was anticipated.  Other studies using the same 
type of thermal stimulus to assess the analgesic effects of intravenously (Kamerling et al. 
1985) and locally (Harkins et al. 1996; Lopez-Sanroman et al. 2003) administered drugs, 
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and to demonstrate local analgesia after acupuncture and electroacupuncture treatment 
(Skarda et al. 2002) did not report conditioning of animals to the testing procedure. 
Preventative measures, such as blindfolding the horses prior to testing (Lopez-Sanroman 
et al. 2003) or intermittent use of an unfocused (sham) light source (Harkins et al. 1996) 
have been used in some protocols, however,  they were not implemented in the present 
study. 
 The effect of ESW application to the third metacarpal bone on LWRL was not 
assessed beyond 48 hours. This follow-up period was chosen based on clinical 
observations in humans (Ogden and Ogden 2002) where the analgesic response appears 
to be biphasic. An immediate initial improvement in clinical signs is normally followed 
by a return of the pain at three to four days after treatment and then a second gradual 
improvement over the ensuing 3 to 4 weeks. The initial response is believed to result 
from the direct effects of shock waves on nociceptors and impaired substance P synthesis, 
whereas the second phase of pain relief is believed to result from a healing response 
associated with angiogenesis and tissue matrix remodeling (Ogden and Ogden 2002). A 
study in sheep, however, failed to identify depletion of the neuropeptides substance P and 
calcitonin gene-related peptide in the soft tissues overlying metacarpi after treatment with 
focused or non-focused ESW (McClure et al. 2003). 
 The results of the present study are contradictory to observations made in another 
investigation where cutaneous analgesia of the overlying skin during the first 72 hours 
after application of focused or non-focused ESW to the third metacarpal bone in horses 
was observed (McClure et al. 2003). In that study, however, cutaneous sensation was 
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assessed only once every 24 hours and an electric stimulus was used to test for local 
cutaneous analgesia (McClure et al. 2003). 
 In people, shock wave therapy is often used to provide relief in painful conditions 
at the soft tissue – bone interface such as tennis elbow, calcific shoulder tendonitis, or 
plantar calcaneal spurs (Haupt 1997; Rompe et al. 1996; Rompe et al. 2001). The rapid 
improvement of clinical signs after ESWT is usually not accompanied by concurrent 
radiographic changes and has been attributed to an analgesic effect that appears to be 
independent of the healing response in tissues (Haupt 1997). Similar observations were 
made in horses with osteoarthritis of the distal intertarsal and tarsometatarsal joints. 
Eighty percent of the horses improved at least one lameness grade and 18% were 
completely sound at 90 days after a single treatment with focused ESWT. No concurrent 
radiographic changes were observed in any of the horses (McCarrol and McClure 2000). 
 Haist and von Keitz-Steiger proposed three hypotheses for shock wave-induced 
analgesia in people: 1) shock waves induce cell damage and the peripheral nociceptors 
can therefore not build up a membrane potential to transmit pain signals; 2) the 
nociceptors are over-stimulated by shock waves and emit high frequency impulses to 
peripheral nerve fibers, which are suppressed by a gate control mechanism; and 3) shock 
wave-induced pericellular free radicals induce the local release of unknown pain-
suppressing substances (Haist and von Keitz-Steeger 1995). 
 Direct effects of ESW on peripheral nerves could contribute substantially to 
regional analgesia after ESWT. A study in isolated frog sciatic nerves revealed repetitive 
generation of action potentials during application of ESW (Schelling et al. 1994). 
Although this in vitro mechanism may not be applicable to the distal equine limb in vivo 
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(McClure et al. 2003), it is possible that ESW could over-stimulate peripheral sensory 
nerve fibers and that signal transmission could be impaired by modulation via a gate 
control-like mechanism (Haist and von Keitz-Steeger 1995). A study in horses revealed a 
significant decrease in sensory nerve conduction velocity in palmar digital nerves after 
direct treatment with non-focused ESW compared with untreated control nerves (Bolt et 
al. 2003). Transmission electron microscopy of treated nerves showed disruption and 
separation within the myelin sheaths of large- to medium-sized myelinated axons (Bolt et 
al. 2003). The lack of a cutaneous analgesic effect in the present study could therefore 
possibly be explained by the absence of peripheral nerves with large myelinated axons in 
the treated areas. 
 It has been recommended to avoid peripheral nerves, large blood vessels and 
growth plates when applying ESWT to horses (McClure and Merritt 2003). However, 
peripheral nerves are often directly targeted when ESW are used to treat conditions in the 
distal limb such as navicular disease (Garcia Lineiro and Echezzareta 2001). Although 
clinical improvement of navicular disease after ESWT has been observed (Baer et al. 
2001; Garcia Lineiro and Echezzareta 2001), an experimental study in horses failed to 
identify local cutaneous analgesia in the heel area following ESW application to the 
palmar digital nerves in the pastern (McClure et al. 2003). 
 In conclusion, the findings of the present study show that a single application of 
non-focused ESW had no noticeable cutaneous analgesic effect in the equine metacarpus. 
These findings, in light of clinical observations of post-treatment analgesia in people and 
horses, results of other experimental studies (McClure et al. 2003), and distinct changes 
in directly treated peripheral nerves after ESW application (Bolt et al. 2003), indicate that 
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this treatment modality should be used cautiously when treating equine athletes in 
training or before competition. 
4.5 Product Information 
aDormosedan, Pfizer, Inc., New York, NY. 
bTorbugesic, Fort Dodge Animal Health, Fort Dodge, IA. 
cSwiss DolorClast® Vet, EMS Electro Medical Systems, Dallas, TX. 
dKamerling SG, Weckman TJ, DeQuick DJ, et al. A method for studying cutaneous pain 
perception and analgesia in horses. J Pharmacol Methods 1985;13:267-274. 
ePROC UNIVARIATE, SAS V8.0, SAS Institute, Inc., Cary, NC. 
fPROC MIXED, SAS V8.0, SAS Institute, Inc., Cary, NC. 
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CHAPTER 5 
SUMMARY 
 In the first study, application of 2,000 pulses of non-focused extracorporeal shock 
waves (ESW) to the palmar digital nerves of horses in the pastern area resulted in 
decreased sensory nerve conduction velocities (SNCV) and caused distinct morphologic 
changes at 3,7 and 35 days after treatment. Morphologic changes detected by 
transmission electron microscopy consisted of an extensive separation and disruption 
between the different layers of the myelin sheath in large- to medium-sized myelinated 
axons. These alterations are compatible with decreased SNCV assessed prior to surgical 
removal of the nerves for morphologic evaluation. No changes were detected in small 
myelinated and non-myelinated axons. Microscopic evaluation revealed varying degrees 
of axonal swelling and cytoplasmic dissolution with a fine granular texture in both treated 
and untreated nerves at all time points. The microscopic changes have therefore to be 
considered artifacts that occurred most likely during the sensory SNCV measurements or 
during the subsequent palmar digital neurectomy. 
 In the second study, no significant difference in nociceptive threshold was found 
between areas of the metacarpus treated with 2,000 pulses of non-focused ESW and 
untreated control areas on the same and on the contralateral metacarpus when cutaneous 
sensation was assessed with a focused light source. Limb withdrawal reflex latency 
(LWRL) responses in all horses were comparable in treated and control areas over time 
with a significant decrease noted at most sites and times compared with baseline 
measurements. Between area comparisons at different times after treatment revealed a 
decrease in LWRL between most sites of the treated limb and the untreated control area 
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of the contralateral metacarpus. These findings may indicate conditioning of the animals 
to the LWRL testing method, although the decrease in LWRL between most areas of the 
treated metacarpus and the non-treated area of the opposite metacarpus may be due to a 
treatment-induced hypersensitivity of the entire dorsal metacarpal surface following 
application of non-focused ESW.  
 Although the findings of these studies do not provide a conclusive explanation for 
the analgesic effect observed after clinical application of ESW, they provide some 
evidence that ESW can induce distinct electrophysiologic and morphologic changes when 
they are administered directly to peripheral nerves. Further investigations are required to 
better understand the analgesic affect after application of ESW in horses and to evaluate 
the effects of repeated ESW applications on function and morphology of peripheral 
nerves.   
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